March 24, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Updated guidance from ACP revealed the best practices for treating confirmed cases of COVID-19 in an outpatient setting, including the use of medications. Amir Qaseem, MD, PhD, MHA, MGIN, MRCP, FACP, ACP’s chief science officer and senior vice president of clinical policy at the Centers for Evidence Reviews, and colleagues published the recommendations in Annals of Internal Medicine.
March 24, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

CHICAGO — Patients with autoimmune and rheumatic diseases who received antiviral therapy for COVID-19 demonstrated reduced…

Clinicians should carefully monitor patients with inflammatory bowel disease and comorbid Clostridioides difficile infection,…

ACCP Position Statement: "Reframing Non-Traditional PharmD Career Opportunities Across Drug Development, Regulatory, and Academia"

Food allergy management is shifting from passive strategies — such as avoidance, carrying epinephrine and hope — to proactive…

ACOG recently issued guidance recommending for the first time that clinicians consider concurrent male sex partner therapy with a…

In this Healio video, Christopher Lock, MD, discusses highlights in anti-amyloid therapies for Alzheimer’s disease presented at…